ArticleFrontiers in pediatrics2026
Clinical profile, reported triggers, and comorbidity pattern in children and adolescents with atopic dermatitis: a cross-sectional study from Fujian, China.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Detailed clinical descriptions of paediatric atopic dermatitis from southern China are scarce; available Chinese data are largely modelled burden estimates or laboratory series of allergen sensitisation. Methods: This single-centre cross-sectional study included 47 children and adolescents aged 3.6-19.0 years meeting the UK Working Party criteria at a tertiary dermatology clinic in Fuzhou, Fujian Province, China. Triggers, comorbidities and family history were extracted from routine records and are reported as recorded histories, not as verified diagnoses or as prevalence estimates. Severity was assessed by body surface area (BSA), a score the assessing dermatologist reports having assigned as a global clinical impression rather than computed from the SCORing Atopic Dermatitis (SCORAD) components, as well as the Patient-Oriented Eczema Measure (POEM) and the Children's Dermatology Life Quality Index. The two source workbooks were audited for copying artefacts, and every value flagged by the audit was checked against the original clinic record. Proportions are reported with Wilson 95% confidence intervals. Results: Median age was 11.0 years (interquartile range 6.0-13.5 years). House dust mite was the most frequently reported trigger (27/47, 57.4%), followed by seafood or crustaceans (40.4%) and a damp environment (21.3%); most participants reported more than one trigger. No specific IgE or skin prick testing was performed, so these are reported triggers only and not sensitisations. A family history of allergic disease was recorded in 95.7% (95% CI 85.8-98.8) and allergic rhinitis in 70.2% (56.0-81.3); the rhinitis figure is partly constitutive of the enrolment criteria, and the family history figure reflects a deliberately broad definition. Recorded asthma was rare (1/44, 2.3%), a record-keeping observation rather than a prevalence estimate. Seventeen values in 10 records were residues of copying between the workbooks and were corrected against the original records. BSA and the severity score correlated within each batch ( Conclusion: House dust mite was the most frequently reported trigger, a recorded history of allergic rhinitis was common, and the disease was predominantly moderate within each batch. Every figure is a recorded-history count reflecting one clinic's ascertainment and its enrolment criteria, not a population prevalence estimate. These are preliminary observations requiring confirmation in larger, prospectively defined, multi-centre cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.